Korea Investment Corp
UTHR icon

Korea Investment Corp’s United Therapeutics UTHR Stock Holding History

Korea Investment Corp’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.64M Sell
17,800
-12,404
-41% -$6.99M 0.02% 492
2026
Q1 		$17.9M Buy
30,204
+17,240
+133% +$8.59M 0.04% 378
2025
Q4 		$6.32M Sell
12,964
-1,120
-8% -$522K 0.01% 570
2025
Q3 		$5.9M Sell
14,084
-17,005
-55% -$5.72M 0.01% 575
2025
Q2 		$8.93M Sell
31,089
-18,300
-37% -$5.47M 0.02% 523
2025
Q1 		$15.2M Buy
49,389
+10,100
+26% +$3.46M 0.04% 417
2024
Q4 		$13.9M Buy
39,289
+2,300
+6% +$845K 0.03% 459
2024
Q3 		$13.3M Buy
36,989
+19,299
+109% +$6.52M 0.03% 428
2024
Q2 		$5.64M Buy
17,690
+11,022
+165% +$2.92M 0.01% 558
2024
Q1 		$1.53M Sell
6,668
-702
-10% -$158K ﹤0.01% 704
2023
Q4 		$1.62M Sell
7,370
-1,137
-13% -$262K ﹤0.01% 701
2023
Q3 		$1.92M Buy
8,507
+3,482
+69% +$802K 0.01% 671
2023
Q2 		$1.11M Sell
5,025
-6,965
-58% -$1.54M ﹤0.01% 715
2023
Q1 		$2.69M Buy
+11,990
New +$2.96M 0.01% 632
2018
Q3 		– Sell
-61,256
Closed -$6.93M – 721
2018
Q2 		$6.93M Sell
61,256
-2,800
-4% -$308K 0.03% 403
2018
Q1 		$7.2M Sell
64,056
-10,444
-14% -$1.33M 0.03% 400
2017
Q4 		$11M Buy
74,500
+17,200
+30% +$2.19M 0.05% 333
2017
Q3 		$6.71M Sell
57,300
-14,400
-20% -$1.84M 0.03% 399
2017
Q2 		$9.3M Sell
71,700
-26,000
-27% -$3.24M 0.04% 340
2017
Q1 		$13.2M Buy
97,700
+1,500
+2% +$227K 0.07% 271
2016
Q4 		$13.8M Sell
96,200
-7,800
-8% -$996K 0.07% 260
2016
Q3 		$12.3M Sell
104,000
-10,400
-9% -$1.25M 0.07% 280
2016
Q2 		$12.1M Buy
114,400
+12,500
+12% +$1.39M 0.07% 272
2016
Q1 		$11.4M Buy
101,900
+50,300
+97% +$6.36M 0.08% 234
2015
Q4 		$8.08M Buy
+51,600
New +$7.51M 0.06% 274
2015
Q3 		– Sell
-13,700
Closed -$2.38M – 648
2015
Q2 		$2.38M Buy
+13,700
New +$2.46M 0.02% 490

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Korea Investment Corp's UTHR Position: Q2 2026 in Review

Korea Investment Corp reduced its United Therapeutics (UTHR) stake by 41% in Q2 2026, selling an estimated $6.99M and leaving 17,800 shares worth $9.64M. The position accounts for 0.02% of the portfolio, ranked #492.

Korea Investment Corp first reported a position in UTHR in Q2 2015 and has held it in 26 quarters since. The position peaked at $17.9M in Q1 2026. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Korea Investment Corp held 17,800 shares of United Therapeutics worth $9.64M as of Q2 2026.
  • Korea Investment Corp sold 12,404 United Therapeutics shares in Q2 2026, an estimated $6.99M.
  • United Therapeutics made up 0.02% of Korea Investment Corp's portfolio in Q2 2026, its #492 holding.
  • Korea Investment Corp first reported a position in United Therapeutics in Q2 2015 and has held it in 26 quarters since.
  • Korea Investment Corp's United Therapeutics position peaked at $17.9M in Q1 2026.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.